NCT03935763
Active, Not Recruiting
N/A
A Real World Evidence Prospective Cohort Study in the Management of Metastatic Colorectal Cancer: A Clinical and Patient Perspective
Servier Affaires Médicales18 sites in 18 countries738 target enrollmentMarch 8, 2019
ConditionsMetastatic Colorectal Cancer
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Metastatic Colorectal Cancer
- Sponsor
- Servier Affaires Médicales
- Enrollment
- 738
- Locations
- 18
- Primary Endpoint
- Overall survival
- Status
- Active, Not Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
A Real World Evidence Prospective Cohort Study in the Management of Metastatic Colorectal Cancer: A Clinical and Patient Perspective
Investigators
Eligibility Criteria
Inclusion Criteria
- •Diagnosis of mCRC
- •Having had two disease progressions since diagnosis of first metastasis that led to first systemic treatment.
Exclusion Criteria
- •Currently participating in an investigational clinical trial (thus it does not apply to observational cohort studies)
- •Currently being treated for other cancer(s)
- •Not having mental capacity and/or ability to participate in the study
Outcomes
Primary Outcomes
Overall survival
Time Frame: From date of randomization until the date of death from any cause, assessed up to 24 months months
metastatic Colorectal Cancer (mCRC) overall survival in real world setting
Secondary Outcomes
- Quality of life using Patients Reported Outcomes(within 18 months from enrollment)
- Disease control measured by overall response(within 18 months from enrollment)
Study Sites (18)
Loading locations...
Similar Trials
Completed
N/A
An Observational Study to Learn More About the Long-Term Responses to Treatment With Regorafenib in Patients With Metastatic Colorectal Cancer in the United StatesMetastatic Colorectal CancerNCT06029010Bayer2,326
Recruiting
N/A
A Clinical Study Aims to Assess the Consistency of Clinical Efficacy in Colorectal Cancer Treatment and Drug Susceptibility Outcomes Using a Novel Drug Susceptibility Testing MethodColorectal CancerOrganoidsNCT06100016Funan Liu105
Active, Not Recruiting
N/A
Retrospective Study on the Use of Immunotherapy in Patients With MSI-H Metastatic Colorectal CancerColorectal CancerNCT04612309Gruppo Oncologico Italiano di Ricerca Clinica100
Recruiting
N/A
Prospective observational study of colorectal cancer examining diagnosis opportunity and risk factors, CRC-DR studyJPRN-UMIN000051316Kyoto Prefectural University of Medicine1,000
Completed
Phase 3
A Study in Second Line Metastatic Colorectal CancerColorectal CancerNCT01183780Eli Lilly and Company1,072